You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -4.9% | -14.3% |
ROCE | 46.5% |
Latest | Forecast | |
---|---|---|
P/E | -41.2 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 1.5 | 1.3 |
Price / Book value | 196.9 |
Latest | Forecast | |
---|---|---|
Revenue | 25.0% | 6.5% |
PBT | 0.0% | n/a |
EPS | 0.0% | -652.2% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 6.13 | -1.49 | -7.00p | -11.9 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 5.04 | -3.12 | -12.40p | -2.3 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 6.74 | -0.65 | -1.50p | -44.7 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 10.09 | 0.25 | 1.40p | 90.4 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 12.61 | -0.62 | -1.30p | -87.7 | 0.0 | n/a | n/a | 0.0% |
Cambridge Cognition secures 'significant contract' Sharecast News | 11 Oct |
---|---|
Cambridge Cognition wins £2m cancer therapy trial contract Sharecast News | 13 Jun |
Cambridge Cognition wins two contracts worth £2.1m Sharecast News | 12 Apr |
Total Voting Rights | 01-Dec-23 07:00 |
---|---|
Change of Auditor | 22-Nov-23 07:00 |
Total Voting Rights | 01-Nov-23 07:00 |
Automated quality assurance for clinical trials | 24-Oct-23 07:00 |
Major contract win combining solutions | 11-Oct-23 23:58 |